跳至主要内容
临床试验/NCT07383532
NCT07383532已完成不适用

Effects of Self-Management Education and Follow-Up Telephone Support on Diabetes Self-Management, Treatment Compliance, and Medication Self-Efficacy in Adults With Type 2 Diabetes

Selcuk University1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2023年5月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
70
试验地点
1
主要终点
Diabetes Self-Management Scale

研究概览

简要总结

This study examined the effects of self-management education combined with follow-up telephone support on diabetes self-management, treatment compliance, and medication self-efficacy in adults with Type 2 diabetes. A total of 70 adults with type 2 diabetes were randomly assigned to an intervention group or a control group. Participants in the intervention group received diabetes self-management education and follow-up telephone support while the control group received usual care. Data were collected using the Personal Information Form, the Diabetes Self-Management Scale, the Patient Adherence Scale for Type 2 Diabetes Mellitus Treatment, and the Diabetes Medication Use Self-Efficacy Scale.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals with a diagnosis of type 2 diabetes for at least 6 months
  • Between the ages of 18-64
  • Planned hospitalisation for at least three days
  • Using only insulin or insulin + oral antidiabetics as treatment

排除标准

  • Individuals with Type 1
  • Gestational diabetes,
  • Communication disability
  • Psychiatric illness
  • Severe complications (retinopathy, neuropathy, nephropathy, diabetic foot, cardiovascular disease)
  • Condition that prevents physical activity
  • Individuals who could not attend at least two sessions of the diabetes education programme

研究组 & 干预措施

Diabetes Self-Management Education and Telephone Support

Experimental

Participants in this arm received a structured diabetes self-management education program combined with follow-up telephone support. The intervention consisted of three face-to-face education sessions covering diabetes self-management, treatment compliance, and medication use. In addition, participants received two structured follow-up telephone support calls over a two-month period to reinforce education content, support adherence, and address participant questions. Outcomes were assessed using pre-test and post-test measurements, including diabetes self-management, treatment compliance, medication self-efficacy, and biochemical parameters

干预措施: Diabetes Self-Management Education and Telephone Support (Behavioral)

Usual Care Control Group

No Intervention

Participants in this arm received usual care for Type 2 diabetes without additional diabetes self-management education or follow-up telephone support. They continued routine clinical follow-up and standard treatment as recommended by healthcare providers. Pre-test and post-test assessments were conducted at the same time points as the intervention group, including measures of diabetes self-management, treatment compliance, medication self-efficacy, and biochemical parameters.

结局指标

主要结局

Diabetes Self-Management Scale

时间窗: Baseline and end of the third month after discharge

The level of diabetes self-management was assessed using the Diabetes Self-Management Scale. The scale evaluates participants' self-management behaviors across four sub-dimensions: glucose management, diet control, physical activity, and utilization of health services. A minimum score of 0 and a maximum score of 10 is obtained from the total scale and sub-dimensions. Higher scores indicating higher levels of diabetes self-management.

次要结局

  • Patient Adherence Scale for Type 2 Diabetes Mellitus Treatment(Baseline and end of the third month after discharge)
  • Diabetes Medication Use Self-efficacy Scale(Baseline and end of the third month after discharge)
  • Glycated hemoglobin(Baseline and end of the third month after discharge)
  • High-density lipoprotein(Baseline and end of the third month after discharge)
  • Low-density lipoprotein(Baseline and end of the third month after discharge)
  • Total cholesterol(Baseline and end of the third month after discharge)
  • Triglyceride(Baseline and end of the third month after discharge)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alime Selçuk Tosun

Associate Professor

Selcuk University

研究点 (1)

Loading locations...

相似试验